Potential Anticancer Agents against Melanoma Cells Based on an As-Synthesized Thiosemicarbazide Derivative
Paweł Kozyra(Medical University of Lublin), Monika Pitucha(Medical University of Lublin), Zbigniew Karczmarzyk(University of Siedlce), Michał Człapski(University of Siedlce), Agnieszka Korga-Plewko(Medical University of Lublin), Marta Ostrowska-Leśko(Medical University of Lublin), Waldemar Wysocki(University of Siedlce), Emilia Fornal(Medical University of Lublin), Anna Hawrył(Medical University of Lublin), Magdalena Iwan(Medical University of Lublin)
Cited by 30
Related Papers
Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells
|BMC Pharmacology and Toxicology|2019|61
Inhibition of glycolysis disrupts cellular antioxidant defense and sensitizes HepG2 cells to doxorubicin treatment
|FEBS Open Bio|2019|50
The effect of a number of H9C2 rat cardiomyocytes passage on repeatability of cytotoxicity study results
|Cytotechnology|2016|48
The Role of Molecular and Inflammatory Indicators in the Assessment of Cognitive Dysfunction in a Mouse Model of Diabetes
|International Journal of Molecular Sciences|2021|43